Literature DB >> 28695809

Diagnosis and Clinical Analysis of Primary Thyroid Lymphoma.

Yong Xie, Wenjing Liu, Yuewu Liu, Wenze Wang, Mengyi Wang, Hongfeng Liu, Xiaoyi Li, Weisheng Gao.   

Abstract

Objective To summarize our experiences in the diagnosis and prognosis of different subtypes of primary thyroid lymphoma (PTL). Methods The clinical data of 27 PTL patients who were treated in our hospital from January 1998 to December 2014 were retrospectively analyzed. The pathological types of these patients included B cell lymphoma unclassifiable (BCLU) (n=5),mucosa-associated lymphiod tissue lymphoma (MALT) (n=9),diffuse large B cell lymphoma (DLBCL) (n=12),and T cell lymphoma (n=1). Results Of all these 27 cases,the most common clinical symptom was painless swelling of the neck (n=21,77.8%). Of 7 patients who had received preoperative fine needle biopsy,lymphoma was suspected in 2 cases (28.6%). Among these 7 cases,the positive rate of suspicious lymphoma was 66.7% in 3 DLBCL patients,0 in 3 MALT patients,and 0 in 1 BCLU paitent. Also,25 patients underwent intraoperative frozen pathological examination,which revealed lymphoma or suspicious lymphoma in 16 cases (64.0%); in these patients,the positive rate was 66.7% for BCLU,77.8% for MALT,58.3% for DLBCL,and 0 for T-cell lymphomas. The overall survival was (89.3±12.4) months,and the overall 5-year survival rate was 61.6%. The estimated survival in symptomatic group was 31.6 months,which was significantly shorter than that in asymptomatic group (97.9 months) (P=0.032). Other factors including age,sex,tumor size,tumor stage,international prognostic index,tracheal compression,lactate dehydrogenase,residual tumor,and pathological type showed no significant effect on survival(all P>0.05). Conclusions DLBCL has the highest fine needle biopsy positive rate,MALT has the highest frozen pathological positive rate,and intraoperative frozen pathology has more malignant results than the preoperative fine needle biopsy in the diagnosis. The accompanying lymphoma symptoms may be an adverse prognostic factor.

Entities:  

Mesh:

Year:  2017        PMID: 28695809     DOI: 10.3881/j.issn.1000-503X.2017.03.013

Source DB:  PubMed          Journal:  Zhongguo Yi Xue Ke Xue Yuan Xue Bao        ISSN: 1000-503X


  4 in total

1.  Approach to primary thyroid lymphoma: case series.

Authors:  Nihan Acar; Turan Acar; Arzu Avcı; Mehmet Haciyanlı
Journal:  Turk J Surg       Date:  2019-06-13

2.  The Risk of Developing Lymphoma among Autoimmune Thyroid Disorder Patients: A Cross-Section Study.

Authors:  Mubarak Al-Mansour; Alaa Fawzi Maglan; Meral Khalid Altayeb; Laila Ali Faraj; Esraa Aman Felimban; Syed Sameer Aga; Mohammad Anwar Khan
Journal:  Dis Markers       Date:  2022-06-03       Impact factor: 3.464

Review 3.  Mucosa-Associated Lymphoid Tissue Lymphoma of the Thyroid Gland: A Systematic Review of the Literature.

Authors:  Evangelos Karvounis; Ioannis Kappas; Anna Angelousi; Georgios-Marios Makris; Eva Kassi
Journal:  Eur Thyroid J       Date:  2019-11-18

4.  Incidence and prognostic factors of primary thyroid lymphoma and construction of prognostic models for post-chemotherapy and postoperative patients: a population-based study.

Authors:  Nan Xiang; Fangyuan Dong; Xuebing Zhan; Shuhan Wang; Junjie Wang; Entao Sun; Bing Chen
Journal:  BMC Endocr Disord       Date:  2021-04-13       Impact factor: 2.763

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.